|Poll|October 9, 2014

Widespread "Yellow Bumps"

Listen

0:00 / 0:00

Key Takeaways

Eruptive xanthomas are linked to poorly controlled diabetes and hyperlipidemia, presenting as sudden-onset yellow papules.
Elevated triglyceride levels are commonly associated with the appearance of eruptive xanthomas in diabetic patients.
Effective management of lipid levels is crucial in preventing dermatological complications in individuals with diabetes.

A woman with poorly controlled type 2 diabetes presented with widespread “yellow bumps" of sudden onset. What's your diagnosis?

This woman with poorly controlled type 2 diabetes presented with widespread “yellow bumps" of sudden onset. Representative lesions across her back and on her elbow can be seen in the Figures.

Of what disorder are the history and clinical picture nearly pathognomonic?

Join thousands of clinicians staying current on new therapies, trial data, and expert insights—subscribe to HCPLive today.

Related to this article

September 21st, 2026

Q&A: Zasocitinib Response in the Scalp, Nails, Palms and Soles

Raj Chovatiya, MD, PhD, on zasocitinib results in the scalp, nails, palms and soles, speed of response and once-daily oral dosing in psoriasis.

September 21st, 2026

PAH Experts Discuss Trial-to-Clinic Mismatch in Care

Philadelphia-area PAH specialists discuss real-world patient mismatch with trial criteria, drug sequencing, and insurance access barriers.

September 21st, 2026

FAQ: What the Expanded Marstacimab Approval Means for Hemophilia A, B

FDA expands marstacimab approval to children and patients with inhibitors, backed by new BASIS trial data.

September 21st, 2026

Binge Drinking and ALD, MetALD Fibrosis Risk, With Frances Lee, MD

Frances Lee, MD, on stigma's role in ALD care and why women may progress to advanced disease faster than men.

September 21st, 2026

Q&A: Zasocitinib's Role Beyond Topicals in Moderate to Severe Psoriasis

In this Q&A, Raj Chovatiya, MD, PhD, discusses where zasocitinib fits in the psoriasis treatment algorithm and what high clearance rates mean for patients.